Check out your Company Bowl for anonymous work chats.
From our CEO, Albert Bourla: "Last Friday, I sent the following note to all US-based Pfizer colleagues. I am sharing it here as a call to action for all Pfizer partners, suppliers and other stakeholders to stand with us and speak up against racial discrimination and injustice. Every person deserves to be seen, heard and cared for, and each one of us has a responsibility to raise our voices to make sure they are."
We are taking a number of steps to scale up manufacturing operations at risk to accelerate our ability to supply a potential novel vaccine for COVID-19, subject to the vaccine demonstrating effectiveness and gaining approval. Learn more here:
Read on to see how RNA vaccines differ from conventional vaccines.
#ScienceWillWin because of scientists like Dr. Annaliesa and many others across our industry who are working on potential breakthroughs for patients. #COVID19 #Coronavirus
Explore what it takes to develop a novel vaccine.
We are all #InItTogether. Learn more about one of the ways we help patients access their Pfizer medicines – today and every day. #PfizerProud
When faced with a new opponent, science doesnât back down. It revs up. We are all #InItTogether and, together, we will work to beat this thing. #ScienceWillWin
Lidia Fonseca, Chief Digital and Technology Officer, and her team are working behind the scenes to ensure our researchers & scientists have the tools they need to find a potential treatment for #COVID19. Find out more from Fast Company.
In the race to develop treatments for #COVID19, we’re working with a compound that was initially identified to treat #SARS. See why our scientists think that the fastest way to find a treatment isn’t to start from scratch, but use something that already exists. #DrugDevelopment #Pharmaceuticals #Coronavirus
Know More: Vice President and Chief Scientific Officer of Viral Vaccines, Phil Dormitzer, discusses COVID19 vaccine research and recovery.
